Prevalence and factors associated with diagnosis of early rheumatoid arthritis in the south of Brazil

Abstract

Background: Rheumatoid arthritis (RA) is an autoimmune inflammatory disease characterized by peripheral and symmetrical polyarthritis. It can be divided into Very Early Rheumatoid Arthritis (VERA) diagnosed up to 3 months of symptoms and late onset (Late Early Rheumatoid Arthritis-LERA), diagnosed between 3 and 12 months. Currently, it is recommended to evaluate the patient with joint symptoms as early as possible, and the first 12 weeks of manifestations represent the ideal phase for the diagnosis, favoring a better evolution of the treatment. The present study aimed to determine the prevalence of early diagnosis of rheumatoid arthritis, mean time of diagnosis and to determine possible associated factors in the municipality of Blumenau, Santa Catarina, Brazil. Methods: A cross-sectional study using the 1987 American College of Rheumatology diagnostic criteria to select patients attended at primary or secondary health care units in Blumenau, Santa Catarina, southern Brazil, in 2014. Diagnostic time was verified by self-report of the time elapsed between the onset of symptoms and the diagnosis made by a rheumatologist. To test the associations, the chi-square test, the Wald linear trend test and the Poisson regression analysis were used. Results: The mean time of diagnosis was 28 months. The prevalence of diagnosis up to 3 and 12 months was 27. 7% and 64.8%, respectively. Obesity was associated with time diagnosis in both periods. The 0-4 years category of the variable education was associated only with the period up to 12 months. Conclusion: The mean time of diagnosis was similar to the national context. Among socioeconomic factors, lower education was associated with the diagnosis of late onset RA. The anthropometric variable presented a progressive increase in the prevalence due to the longer time to diagnosis.

Impact of clinical and psychological factors associated with depression in patients with rheumatoid arthritis: comparative study between Germany and Brazil

“…In Germany, the time between onset of symptoms and presentation to a rheumatologist could be reduced to 9 months [35,36]. In contrast, recent studies in Brazil demonstrated a huge variation of the interval between onset of symptoms and diagnosis of a rheumatic disease, ranging in the REAL study from one to 457 months (median 12 months) and a mean of 28 months in a study from the country's south [32,37]. Both studies show that almost 80% of the RA patients in Brazil were of middle-low or low socioeconomic status, and the delay in diagnosing RA was associated with lower socioeconomic status and lower education level of the patients [38].…”

Safety of Coronavac and ChAdOx1 Vaccines Against SARS-CoV-2 in Patients with Rheumatoid Arthritis Data from the Brazilian Multicentric Study Safer

“…In the present study, most patients with RA were female, brown, with a mean age of 45, data similar to other previously puplished studies. 18,19,20 In our sample, the average age in the 45-year-old range is justi ed by the low inclusion of elderly people, most of whom had already been vaccinated when the project started, in May 2021, making their participation in this cohort unfeasible.…”

Artrite reumatoide: visão ampla de abordagens atualizadas / Rheumatoid arthritis: updated approaches

“…A AR diagnosticada precocemente, ou seja, em até 3 meses após as primeiras manifestações, evidencia uma resposta terapêutica significativamente mais eficaz. Infelizmente, um recente estudo transversal brasileiro concluiu que a realidade para população estudada é bem diferente, sendo o tempo médio até o diagnóstico de 28 meses (GOMES et al, 2018).…”